A recent study compared clinical and biochemical characteristics of patients with severe hypertriglyceridemia, distinguishing familial chylomicronemia syndrome from multifactorial chylomicronemia syndrome.
...
A phase 3 clinical trial demonstrates the efficacy of olezarsen in reducing plasma triglycerides and acute pancreatitis episodes in patients with familial chylomicronemia syndrome.
